Saskia van den Dool leads the IMAGING4DRUGS programme at UMCG, a national research infrastructure within PharmaNL building an integrated molecular imaging capability that accelerates drug development by connecting academic researchers, clinicians, imaging facilities, technology platforms and industry.

She brings more than 30 years across medical imaging, medtech, biotech and health IT, including senior leadership roles at Carestream Health and Swisslog Healthcare. As Founder & COO of Sabiad and Managing Partner at TVH Life Science Partners, she works at the intersection of research, healthcare and investment, translating scientific innovation into credible development and commercialization pathways.

In IMAGING4DRUGS she connects a complex ecosystem of institutions, core facilities, industry partners and funders, turning ambiguity into structure and maintaining momentum toward shared national objectives.